Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

AZD1775 in Treating Patients With Advanced Refractory Solid Tumors With CCNE1 Amplification

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03253679
Recruitment Status : Suspended (Other - Protocol amendment required for expansion)
First Posted : August 18, 2017
Last Update Posted : October 20, 2020
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : September 30, 2021
Estimated Study Completion Date : September 30, 2021